Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule
Clinical trial NCT02824198 · COMPLETED
Trial details
- NCT number
- NCT02824198
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-03-18
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.